Rodegerdts et al., 2000 - Google Patents
In vitro evaluation of teratogenic effects by time‐varying MR gradient fields on fetal human fibroblastsRodegerdts et al., 2000
View PDF- Document ID
- 12812181986579135490
- Author
- Rodegerdts E
- Grönewäller E
- Kehlbach R
- Roth P
- Wiskirchen J
- Gebert R
- Claussen C
- Duda S
- Publication year
- Publication venue
- Journal of Magnetic Resonance Imaging
External Links
Snippet
The purpose of this study was to evaluate the influence on fetal cell growth in vitro of rapidly changing magnetic gradient fields such as those produced by the gradient coils of a typical magnetic resonance (MR) imager. The static magnetic field and the radiofrequency pulses …
- 230000001605 fetal 0 title abstract description 14
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/381—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using electromagnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/385—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using gradient magnetic field coils
- G01R33/3854—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using gradient magnetic field coils means for active and/or passive vibration damping or acoustical noise suppression in gradient magnet coil systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/3806—Open magnet assemblies for improved access to the sample, e.g. C-type or U-type magnets
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/387—Compensation of inhomogeneities
- G01R33/3873—Compensation of inhomogeneities using ferromagnetic bodies; Passive shimming
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/288—Provisions within MR facilities for enhancing safety during MR, e.g. reduction of the specific absorption rate [SAR], detection of ferromagnetic objects in the scanner room
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Budinger et al. | MRI and MRS of the human brain at magnetic fields of 14 T to 20 T: Technical feasibility, safety, and neuroscience horizons | |
Kangarlu et al. | Biological effects and health implications in magnetic resonance imaging | |
Basser | Relationships between diffusion tensor and q‐space MRI | |
Thulborn et al. | Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging | |
Rodegerdts et al. | In vitro evaluation of teratogenic effects by time‐varying MR gradient fields on fetal human fibroblasts | |
Rad et al. | Quantification of superparamagnetic iron oxide (SPIO)‐labeled cells using MRI | |
Fatahi et al. | Magnetic resonance imaging (MRI): A review of genetic damage investigations | |
Persson et al. | Health and safety of clinical NMR examinations | |
Chenevert et al. | Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors | |
Blackman et al. | A role for the magnetic field in the radiation‐induced efflux of calcium ions from brain tissue in vitro | |
McRobbie | Occupational exposure in MRI | |
Yablonskiy et al. | Statistical model for diffusion attenuated MR signal | |
Keilholz et al. | Functional MRI of the rodent somatosensory pathway using multislice echo planar imaging | |
Valonen et al. | Water diffusion in a rat glioma during ganciclovir‐thymidine kinase gene therapy‐induced programmed cell death in vivo: correlation with cell density | |
Wiskirchen et al. | Long‐term effects of repetitive exposure to a static magnetic field (1.5 T) on proliferation of human fetal lung fibroblasts | |
Frankel et al. | Biological effects of static magnetic fields | |
Wiskirchen et al. | Human fetal lung fibroblasts: in vitro study of repetitive magnetic field exposure at 0.2, 1.0, and 1.5 T | |
Hardy et al. | On the transverse relaxation rate enhancement induced by diffusion of spins through inhomogeneous fields | |
Schiffer et al. | No influence of magnetic fields on cell cycle progression using conditions relevant for patients during MRI | |
Brekke et al. | The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry | |
Geng et al. | Tracking of mesenchymal stem cells labeled with gadolinium diethylenetriamine pentaacetic acid by 7T magnetic resonance imaging in a model of cerebral ischemia | |
Weinreb et al. | Magnetic resonance imaging of hepatic lymphoma | |
Ramaswamy et al. | Superparamagnetic iron oxide (SPIO) labeling efficiency and subsequent MRI tracking of native cell populations pertinent to pulmonary heart valve tissue engineering studies | |
Ueno | Studies on magnetism and bioelectromagnetics for 45 years: From magnetic analog memory to human brain stimulation and imaging | |
Frankel et al. | Assessing exposures to magnetic resonance imaging’s complex mixture of magnetic fields for in vivo, in vitro, and epidemiologic studies of health effects for staff and patients |